Responses
Imaging
Original article
Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.